Zobrazeno 1 - 10
of 42
pro vyhledávání: '"L, Chap"'
Publikováno v:
Cancer Research. 79:P6-18
Background: Addition of ribociclib to aromatase inhibitors significantly increased median progression-free survival in postmenopausal women in the MONALEESA-2 trial and premenopausal women in the MONALEESA-7 trial with hormone receptor–positive (HR
Autor:
James J. Vredenburgh, John A. Glaspy, Brian J. Bolwell, L. Chap, Beth Overmoyer, Dora Menchaca, S. Cruickshank, C. Gilbert
Publikováno v:
Bone Marrow Transplantation. 26:141-145
Forty-seven patients with stage II, III, or IV breast cancer undergoing autologous peripheral blood progenitor cell (PBPC) transplantation were randomized to placebo (n = 13) or to one of five sequential dose cohorts of pegylated (PEG) recombinant hu
Publikováno v:
Bone Marrow Transplantation. 20:1063-1067
Drug-induced pulmonary toxicity is one of the most frequent non-hematologic toxicities in breast cancer patients receiving high-dose chemotherapy with cyclophosphamide, cisplatin and BCNU (CY/CDDP/BCNU). A non-invasive clinical scoring system was uti
Autor:
Roy B. Jones, L. Chap, Ian McNiece, Elizabeth J. Shpall, William P. Sheridan, Michael Lill, C. F. LeMaistre, S. A. Turner, John A. Glaspy, M. D. Wiers, Dora Menchaca, Robert A. Briddell
Publikováno v:
Blood. 90:2939-2951
The safety and optimal dose and schedule of stem cell factor (SCF ) administered in combination with filgrastim for the mobilization of peripheral blood progenitor cells (PBPCs) was determined in 215 patients with high-risk breast cancer. Patients re
Publikováno v:
Skeletal Radiology. 23:143-147
We presented the case of a 26-year-old woman with a blastic, miliary form of osteosarcomatosis involving the axial skeleton, skull, and long bones to the elbow and knee joint regions who subsequently developed hypocalcemic tetany. Radiologically the
Autor:
J A, Glaspy, E J, Shpall, C F, LeMaistre, R A, Briddell, D M, Menchaca, S A, Turner, M, Lill, L, Chap, R, Jones, M D, Wiers, W P, Sheridan, I K, McNiece
Publikováno v:
Blood. 90(8)
The safety and optimal dose and schedule of stem cell factor (SCF) administered in combination with filgrastim for the mobilization of peripheral blood progenitor cells (PBPCs) was determined in 215 patients with high-risk breast cancer. Patients rec
Publikováno v:
The cancer journal from Scientific American. 2(1)
Publikováno v:
Skeletal radiology. 23(2)
We presented the case of a 26-year-old woman with a blastic, miliary form of osteosarcomatosis involving the axial skeleton, skull, and long bones to the elbow and knee joint regions who subsequently developed hypocalcemic tetany. Radiologically the
Publikováno v:
Bone marrow transplantation. 12(2)
GM-CSF has been used successfully in autologous BMTs, and more recently in patients undergoing allogeneic BMT, for acute or chronic leukemia. We report two patients with hepatitis-related aplastic anemia who received recombinant human GM-CSF followin
Autor:
Isabelle Tabah-Fisch, G. Von Minckwitz, John R. Mackey, John Crown, Wolfgang Eiermann, Henry Taupin, Louise Provencher, Tadeusz Pienkowski, DJ Slamon, S. Sehdev, Mansoor N. Saleh, M. Pawlicki, Vladimir Semiglazov, Marc Buyse, L Chap, Miguel Martín, Guido Sauter, Alessandro Riva
Publikováno v:
Cancer Research. 69:77
Abstract #77 Background: The relative benefits of adjuvant breast cancer chemotherapy with docetaxel in combination with anthracycline, or given sequentially after an anthracycline-based regimen, are unknown. Material and Methods: We randomized women